enVVeno Medical Corp (NASDAQ: NVNO) is a medical device company focused on developing a product candidate for commercialization, pending regulatory approval. The company has no disclosed revenue as of the fiscal year ended December 31, 2025, operating as a pre-commercial stage enterprise dependent on external financing. The 10-K filed March 26, 2026 notes the company has no sales infrastructure and limited marketing capability, and has raised capital through equity offerings including an at-the-market facility established with Ladenburg Thalmann & Co. Inc. in October 2025. The filing discloses reliance on a single facility whose loss could materially disrupt operations. No product approvals, commercial sales, or revenue figures are disclosed in the filing excerpts provided.

Revenue model

No revenue disclosed in the filing excerpts for FY2025. The company has raised capital through equity issuances and warrant transactions. An at-the-market offering agreement with Ladenburg Thalmann & Co. Inc. was entered into as of October 30, 2025.

Products and services

The filing references a product candidate subject to regulatory approval. No approved or commercially available products are identified in the filing excerpts.

Customers and end markets

No customers or commercial end markets are disclosed in the filing excerpts. The company is subject to federal healthcare regulations including the physician sunshine requirements under the PPACA, indicating an intended end market in healthcare.

Value-chain role

Pre-commercial medical device developer operating upstream of commercialization, with no disclosed manufacturing at scale or distribution partnerships in the filing excerpts.

Geographic exposure

Incorporated and operating in the United States, subject to U.S. federal and state healthcare regulations. No international operations disclosed in the filing excerpts.

Source: SEC 10-K, filed 2026-03-26

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Cytosorbents Corp Daxor Corp Pulse Biosciences Inc LENSAR Inc Lucid Diagnostics Inc Neuronetics Inc Pro-Dex Inc